Odyssey Therapeutics, Inc. (ODTX) Net Margin
- 2025-06-30: Net Margin -4299.79%.
- 2025-03-31: Net Margin -2003.91%.
Complete source-backed net margin history.
- Available history
- 2025-03-31 to 2025-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2025-06-30 | -4299.79% |
| 2025-03-31 | -2003.91% |
Annual Net Margin
| Date | Net Margin |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |